OTCMUMAX
Market cap0kUSD
Dec 16, Last price
0.00USD
Jan 2017
-99.99%
IPO
-100.00%
Name
Umax Group Corp
Chart & Performance
P/E
—
P/S
0.01
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
43k
-23.23%
Net income
-365k
L
CFO
-288k
L
Profile
UMAX Group Corp., a development stage company, doing business as UMAX Nutrition, focuses on developing and distributing natural and organic nutrition, and dietary supplements to the nutritional industry. Its product line provides dietary needs for weight loss, colon health, sexual health, body building, and general health and vitality. The company's products include UPRITE XXL, a natural herbal male enhancement supplement providing an alternative to prescription erectile dysfunction medication; green coffee bean extract; and RASPBERRY KETONE, an anti-oxidant and fat burning ingredient. UMAX Group Corp. was founded in 2011 and is based in Los Angeles, California.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2023‑04 | 2022‑04 | 2021‑04 | 2020‑04 | 2018‑04 | 2017‑04 | |
| Income | ||||||
Revenues | 43 -23.23% | 56 -91.07% | ||||
Cost of revenue | 94 | 371 | ||||
Unusual Expense (Income) | ||||||
NOPBT | (51) | (315) | ||||
NOPBT Margin | ||||||
Operating Taxes | 4 | |||||
Tax Rate | ||||||
NOPAT | (51) | (315) | ||||
Net income | (365) -102.10% | 17,398 -10,827.40% | ||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | 2,382 | 2,065 | ||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | 200 | |||||
Net debt | 956 | 869 | ||||
| Cash flow | ||||||
Cash from operating activities | (288) | 19,509 | ||||
CAPEX | ||||||
Cash from investing activities | (246) | (237) | ||||
Cash from financing activities | 517 | 921 | ||||
FCF | 43 | 1,158 | ||||
| Balance | ||||||
Cash | 346 | 18 | ||||
Long term investments | 1,426 | 1,179 | ||||
Excess cash | 1,424 | 1,194 | ||||
Stockholders' equity | (5,754) | (5,389) | ||||
Invested Capital | 6,914 | 6,396 | ||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | 561,472 | 561,472 | ||||
Price | 0.00 -93.22% | 0.03 -87.71% | ||||
Market cap | 1,123 -93.22% | 16,563 -87.71% | ||||
EV | 2,084 | 17,438 | ||||
EBITDA | (37) | (286) | ||||
EV/EBITDA | ||||||
Interest | 12 | 200 | ||||
Interest/NOPBT | ||||||